Name: UMIN ID:
Unique ID issued by UMIN | UMIN000033159 |
---|---|
Receipt number | R000037816 |
Scientific Title | Phase2 Clinical Trial of Hepatocyte Growth Factor Gene Therapy for Primary Lymphedema |
Date of disclosure of the study information | 2018/07/01 |
Last modified on | 2022/06/29 09:31:44 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2018/06/27 12:15:42 | ||
2 | Update | 2018/08/22 10:20:48 | Recruitment status |
|
3 | Update | 2019/03/01 14:24:51 | Recruitment status |
|
4 | Update | 2019/07/01 11:58:47 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
5 | Update | 2019/07/01 12:02:45 | Date of IRB Last follow-up date |
|
6 | Update | 2020/03/05 16:02:39 | Anticipated trial start date Last follow-up date Date of closure to data entry Date trial data considered complete |
|
7 | Update | 2020/07/01 08:48:14 | Date analysis concluded |
|
8 | Update | 2022/06/29 09:31:44 | Recruitment status |